ÂÜÀòÂÒÂ×

Ana Belén García Delgado, PhD, is a postdoctoral researcher at the Universidad de Sevilla since January 2022, with a focus on neuroscience and advanced therapies for degenerative diseases. Previously, from March 2021 to December 2022, Ana served as a researcher at Fundación Progreso y Salud, leading the generation of brain organoids from iPSCs derived from amyotrophic lateral sclerosis patients. Prior experience includes a predoctoral researcher position at CABIMER, concentrating on retinal degeneration, and various laboratory roles involving cell culture and molecular techniques. Ana holds a Licentiate degree in Pharmacy from Universidad de Sevilla, a Master's in Advanced Therapy Medicinal Products from Universidad de Granada, and a Master's in Health Biotechnology from Universidad Pablo de Olavide.